Medindia

U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

Contacts: Investors                                                                                              Media Traci McCarty Katherine ...

BioMarin Pharmaceutical Inc.: U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the ...
Scientific Research Publishing

Arsenic Encephalopathy Associated with Excessive Seafood Consumption: A Case Report ()

Arsenic toxicity is an uncommon and frequently underrecognized cause of subacute encephalopathy. Diagnosis requires careful integration of exposure history, clinical findings, and laboratory testing, ...